89 related articles for article (PubMed ID: 8484676)
1. Severe cutaneous necrosis in antiphospholipid syndrome.
Mostafa M; Mahmoud A; Egiza HA; Niu C; Elbahnasawy M; Yusuf Y; Kouides P
Am J Hematol; 2023 Nov; 98(11):E328-E333. PubMed ID: 37713504
[No Abstract] [Full Text] [Related]
2. Systemic lupus erythematosus and Raynaud's phenomenon.
Heimovski FE; Simioni JA; Skare TL
An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
[TBL] [Abstract][Full Text] [Related]
3. Livedo reticularis: A review of the literature.
Sajjan VV; Lunge S; Swamy MB; Pandit AM
Indian Dermatol Online J; 2015; 6(5):315-21. PubMed ID: 26500860
[TBL] [Abstract][Full Text] [Related]
4. Acrocyanosis: the Flying Dutchman.
Kurklinsky AK; Miller VM; Rooke TW
Vasc Med; 2011 Aug; 16(4):288-301. PubMed ID: 21427140
[TBL] [Abstract][Full Text] [Related]
5. Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.
Shovman O; Gilburd B; Barzilai O; Langevitz P; Shoenfeld Y
Clin Rev Allergy Immunol; 2007 Apr; 32(2):145-52. PubMed ID: 17916984
[TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid antibody syndrome].
Schmidt R; Scheuermann EH; Viertel A; Geiger H; Scharrer I
Med Klin (Munich); 1999 Feb; 94(2):93-100. PubMed ID: 10194954
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study.
Naldi L; Locati F; Marchesi L; Cortelazzo S; Finazzi G; Galli M; Brevi A; Cainelli T; Barbui T
Ann Rheum Dis; 1993 Mar; 52(3):219-22. PubMed ID: 8484676
[TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
Romicka AM; Gazda A; Zabek J; Wojciechowska B
Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
[No Abstract] [Full Text] [Related]
9. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
10. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance].
Wisløff F; Sletnes KE; Schjetlein R
Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations associated with antiphospholipid antibodies.
Diógenes MJ; Diógenes PC; de Morais Carneiro RM; Neto CC; Duarte FB; Holanda RR
Int J Dermatol; 2004 Sep; 43(9):632-7. PubMed ID: 15357740
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for arterial thrombosis in antiphospholipid syndrome.
Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
[TBL] [Abstract][Full Text] [Related]
13. Microvascular pattern and blood stasis in skin disease.
Ryan TJ; Copeman PW
Br J Dermatol; 1969 Aug; 81(8):563-73. PubMed ID: 4895571
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
